Toshimichi Ueda

Direttore/Membro del Consiglio presso SIGNPOST CORPORATION

56 anni

Health Services

Consumer Services

Posizioni attive di Toshimichi Ueda

Società	Posizione	Inizio	Fine
SIGNPOST CORPORATION	Direttore/Membro del Consiglio	30/05/2018	-
SIGNPOST CORPORATION	Independent Dir/Board Member	30/05/2018	-
SanBio, Inc. SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA.	Comptroller/Controller/Auditor	-	-
	Direttore/Membro del Consiglio	-	-
Hibiki Partners Co., Ltd.	Direttore/Membro del Consiglio	01/09/2012	-
Hibiki Partners Co., Ltd.	Corporate Officer/Principal	01/09/2012	-

Keio University

Undergraduate Degree

Distribuzione geografica

Giappone	4
Stati Uniti	2

Posizioni

Director/Board Member	3
Comptroller/Controller/Auditor	1
Undergraduate Degree	1

Settori

Health Services	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
SIGNPOST CORPORATION	Health Services

Aziende private	2
SanBio, Inc. SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA.	Health Services
Hibiki Partners Co., Ltd.

Aziende private

Health Services

Hibiki Partners Co., Ltd.